APT Medical Inc.

Equities

688617

CNE100004C45

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 11/06/2025			5-day change	1st Jan Change
407.63 ^CNY	+3.00%		+4.53%	+9.48%

04-23	APT Medical Q1 Profit Rises 31%; Shares Down 5%	MT
04-23	APT Medical's 2024 Profit Rises 26%, Operating Income Climbs 25%; Shares Drop 4%	MT

Tranche Update on APT Medical Inc.'s Equity Buyback Plan announced on June 15, 2022.

Published on 04/04/2023 at 23:00

From April 1, 2023 to April 4, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 311,808 shares, representing 0.47% for CNY 59.99 million under the buyback announced on June 15, 2022.

Latest news about APT Medical Inc.

APT Medical Q1 Profit Rises 31%; Shares Down 5%	04-23	MT
APT Medical's 2024 Profit Rises 26%, Operating Income Climbs 25%; Shares Drop 4%	04-23	MT
APT Medical Says 2024 Net Profit Up 26.1% Y/Y	04-22	RE
APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	04-22	CI
APT Medical Gets Registration Certificate for Vena Cava Filter System	03-05	MT
APT Medical Gets Medical Device Registration for Medical Catheter Sensor	02-27	MT
APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	02-24	CI
Certain A Shares of APT Medical Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2025.	01-05	CI
China Approves APT Medical Unit's Atrial Fibrillation Treatment Device	12-19	MT
APT Medical Gets Registration Certificate for Two Cardiac Devices	12-17	MT
Shanghai HongTong Industrial Co., Ltd. announced that it expects to receive CNY 700 million in funding from APT Medical Inc.	12-11	CI
APT Medical Inc. Reports Earnings Results for the Nine Months Ended September 30, 2024	25/10/24	CI
APT Medical Inc.(XSSC:688617) added to FTSE All-World Index	22/09/24	CI
APT Medical's H1 Profit Rises 33%, Operating Income Climbs 27%; Shares Drop 3%	23/08/24	MT
APT Medical Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	22/08/24	CI
APT Medical Gets Registration Certificate for Catheter	08/08/24	MT
APT Medical Inc. Announces Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders.	29/04/24	CI
APT Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04/24	CI
Shenzhen Mindray Technology Announces Nominees for the Company's Second Board of Directors and Supervisory Board to APT Medical Inc.	16/04/24	CI
Shenzhen Mindray Technology Holdings Co., Ltd. completed the acquisition of 19.72% stake in APT Medical Inc. from group of sellers.	14/04/24	CI
APT Medical's 2023 Profit Jumps 49%	25/03/24	MT
APT Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02/24	CI
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan	31/01/24	MT
Chinese medical device firm Mindray plans $927 million deal to control APT Medical	29/01/24	RE
Shenzhen Mindray Technology Holdings Co., Ltd. agreed to acquire 19.72% stake in APT Medical Inc. from variou sellers for CNY6.2 billion.	28/01/24	CI

Chart APT Medical Inc.

Duration

Period

688617: Dynamic Chart

Company Profile

APT Medical Inc is a China-based company mainly engaged in the research and development, manufacture and sales of electrophysiological and vascular interventional medical devices. The Company's electrophysiological products include electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters and multichannel electrophysiological systems. Its coronary artery access products mainly include guide wires, micro catheters, balloons, contrast guide wires and catheters. The Company's peripheral vascular intervention products are mainly applied in peripheral vascular diseases. The Company is also engaged in related original equipment manufacturer (OEM) business. The Company distributes its products within domestic market and to overseas markets.

Employees

2,555

Sector

Medical Equipment, Supplies & Distribution

Calendar

08-20 - Q2 2025 Earnings Release (Projected)

More about the company